Automata raises $50M for life sciences automation

Automata, a company focused on life sciences automation, raised $50 million in Series B funding. The company plans to use the financing to further develop its lab automation platform, Automata Labs, for use in and outside of the UK. Automata Labs was created to make scaling up easy for diagnostics labs, drug discovery labs and more. The company claims its system can be implemented within weeks and can automate each stage of workflow. It also offers a flexible robot arm called Eva.